glp 1 and kidney disease Renal effects of GLP-1 receptor agonists tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine New Hope for Kidney Disease:
Description
10.1056/NEJMoa2401943
"We discovered that patients are saying 'I used to not go to the gym because I was so overweight and felt very self-conscious, but after GLP-1s I kind of got to a place where I didn't feel embarrassed going to the gym,'" Pye said
27 and Supplementary Figs
Hughes S, Neumiller JJ
Pastori D, Farcomeni A, Milanese A et al (2020) Statins and major adverse limb events in patients with peripheral artery disease: a systematic review and meta-analysis
She has the privilege of serving as the nutrition director for UC Irvines Susan Samuel Integrative and Functional Medicine Fellowship, as well
